#Immuno Oncology Assays Market size

[marketreports-blog]

The global Immuno Oncology Assays market size was estimated at USD 5.52 billion in 2022 and is expected to surpass around USD 18.08 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 12.6% during the forecast period 2023 to 2032.

[gauricmi]

Global Immuno-Oncology Assays Market Is Estimated To Witness High Growth Owing To Increased Research and Development in Cancer Immunotherapy and Rising Prevalence of Cancer

The global immuno-oncology assays market is estimated to be valued at US$3,718.5 Mn in 2021 and is expected to exhibit a CAGR of 10.7% over the forecast period 2022-2028.

A) Market Overview:

The immuno-oncology assays market is witnessing significant growth due to the increasing research and development in cancer immunotherapy. Immuno-oncology assays play a crucial role in understanding the interaction between the immune system and cancer cells, which helps in developing effective treatments for cancer. These assays are used to analyze immune cell function, monitor tumor immune response, and evaluate the efficacy of immunotherapeutic drugs. The immuno-oncology assays market includes various products such as flow cytometers, immunoassays, PCR instruments, next-generation sequencing (NGS) systems, and others.

B) Market Dynamics:

The Immuno-Oncology Assays Market is driven by two major factors. The first driver is the increased research and development in cancer immunotherapy. With the growing understanding of the immune system and its role in cancer, researchers are focusing on developing innovative immunotherapeutic approaches. Immuno-oncology assays are essential for evaluating the safety and efficacy of immunotherapies, which in turn boosts market growth.

The second driver is the rising prevalence of cancer worldwide. According to the World Health Organization (WHO), cancer is the second leading cause of death globally. The increasing incidence of cancer and the need for effective treatments are driving the demand for immuno-oncology assays. These assays enable personalized cancer treatment by identifying specific biomarkers and predicting patient response to immunotherapy.

C) SWOT Analysis:

Strength: Increasing research and development in cancer immunotherapy, and rising prevalence of cancer.

Weakness: High cost of immuno-oncology assays and limited access to advanced healthcare infrastructure in developing countries.

Opportunity: Growing adoption of precision medicine and advancements in technology for immuno-oncology assays.

Threats: Stringent regulatory requirements for drug approval and potential side effects of immunotherapies.

D) Key Takeaways:

In terms of market size, the global immuno-oncology assays market is expected to witness high growth, exhibiting a CAGR of 10.7% over the forecast period. This growth can be attributed to the increasing research and development in cancer immunotherapy and the rising prevalence of cancer.

In terms of regional analysis, North America is expected to dominate the immuno-oncology assays market due to the presence of key market players, well-established healthcare infrastructure, and high adoption of advanced technologies. Europe is also expected to contribute significantly to market growth, driven by increasing funding for cancer research and growing government initiatives for the development of precision medicine.

Key players operating in the global immuno-oncology assays market include Charles River, Roche, Illumina, and Agilent Technologies, Inc. These companies are focusing on strategic partnerships, collaborations, and acquisitions to strengthen their market position and expand their product portfolio.

In conclusion, the global immuno-oncology assays market is witnessing significant growth due to increased research and development in cancer immunotherapy and the rising prevalence of cancer. The market is expected to exhibit high growth over the forecast period, driven by advancements in technology and the growing adoption of precision medicine. Key players in the market are actively involved in strategic initiatives to maintain their competitive edge.

[soumyafwr]

https://social.studentb.eu/read-blog/163922_immuno-oncology-assays-market-size-share-and-forecast-2031.html

Immuno Oncology Assays Market Size, Share and Forecast 2031

[myabhijitr]

Immuno Oncology Assays Market Size, Share, Outlook, and Analysis, 2019-2027

Immuno oncology assays are referred to as a next generation sequencing application. Immuno oncology assays help to maintain cell morphology as well as cell health for real time measurements or continuous analysis. The immuno oncology assays market includes assays such as T cell assays, Tumor killing assays, Tumor cell assays, Natural killer cell assays, Macrophage assays, and Dendritic cell assays.

New product launches are expected to propel growth of the immuno oncology market during the forecast period. For instance, in April 2019, Roche Diagnostics launched the new VENTANA HER2 Dual ISH DNA Probe Cocktail assay for identification of human epidermal growth factor receptor 2 (HER2) biomarker in breast and gastric cancers.

Request Sample Copy of This Report: https://www.coherentmarketinsights.com/insight/request-sample/2632

Furthermore, key players in the market are focused on launching new immuno oncology assays, which is expected to drive growth of the immune oncology assays market. For instance, in August 2018, Thermo Fisher Scientific announced that it has validated Thermo Oncomine Tumor Mutation Load Assay for clinical trials which is a latest approach in the immuno-oncology treatment. Hence, it is expected to become a rapid and independent predictor for patient’s satisfaction and response to cancer treatment.

Increasing challenges in significant production of immuno oncology assays is expected to hinder the market growth. Production of immuno-oncology assays needs specialist teams and experienced investigators. Furthermore, the cost for production of immuno-oncology assays is costly and time consuming which is expected to restrain growth of the immuno-oncology market growth.

The North America region is expected to hold dominant position in the immuno oncology assay market owing to collaboration strategies adopted by various key players for technological advancements. For instance, in May 2018, Five Prime Therapeutics collaborated with Roche Diagnostics, for development and validation of CDx assay (a companion diagnostic assay).

Furthermore, Asia Pacific is projected to witness significant growth in the global immuno oncology assays market, owing to increasing launches of immuno oncology assays in the immuno oncology assays market. For instance, in April 2018, BellBrook Labs (Headquartered in China), released new Transcreener cGAS Activity Assays designed specifically for cancer treatment and autoimmune disorders.

More Information On This Report: https://www.coherentmarketinsights.com/ongoing-insight/immuno-oncology-assays-market-2632

Key players operating in the immuno oncology market are Roche Diagnostics, Agilent Technologies, Qiagen, Merck, Thermo Fischer scientific, HTG Molecular Diagnostics, Perkinelmer, Sartorius AG, and lllumina, Merck, Perkinelmer.

[roshansalunke328]

QY Research Medical published a comprehensive research on Immuno Oncology Assays Kit Market, which provides a business strategies, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

[vynzresearchindia]

Global Immunoassay Market Size, Share, Demand and Growth Forecast to 2030 | VynZ Research

The Global Immunoassay Market size will reach USD 31.9 Billion by 2030 and is expected to develop at a CAGR of 7.1% during the forecast period (2022-2030), according to VynZ Research. For the forecast year 2022-2030, as well as the historical period 2018-2021, the Global Immunoassay Market has been studied.

The research report provides a comprehensive and insightful examination of the Global Immunoassay Market and includes market analysis on segmentation, dynamics, competition, and regional development. It considers the Global Immunoassay Market's CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, pricing, and other significant parameters. The forecasts in the report are based on well-established research methodology and assumptions.

Explore the recent findings of the Global Immunoassay Market by purchasing a single user PDF@ https://www.vynzresearch.com/healthcare/immunoassay-market/request-sample

Individual strategies were examined in the Global Immunoassay Market study, followed by business profiles of Global Immunoassay Market providers. The study includes an 'Industry Landscape' section that provides readers with a comprehensive view and firms’ market share analysis of major industry players in the Global Immunoassay Market.

Most of the major players in the Global Immunoassay Market are profiled in the report. The strengths and weaknesses, business developments, recent innovations, mergers and acquisitions, expansion plans, global footprint, market presence, and product portfolios of key market competitors are all covered in the company profiling section.

The following are some of the major and developing players in the Global Immunoassay Market:

·         Roche

·         Agilent Technologies

·         Abbott Laboratories

·         Thermo Fisher Scientific

·         Siemens

·         QIAGEN

·         Danaher

·         Ortho Clinical Diagnostics

·         Sysmex

·         Bio-Rad Laboratories

·         BioMérieux

·         Becton

·         Dickinson & Company

·         Mindray

Breakdown of The Segments:

The Global Immunoassay Market is segmented by Product and Service, Platform, Technology, Specimen Type, Application, End-User, and Geography in this study. This segmentation aids executives in planning their products and budgets depending on each segment's expected growth rates.

Product & Services Insight and Forecast 2022-2030

·         Analyzers

·         Reagents & Kit

·         Software

·         Services

Platform Insight and Forecast 2022-2030

·         Chemiluminescence

·         Colorimetric

·         Fluorescence

·         Radioimmunoassays

·         Others

Technology Insight and Forecast 2022-2030

·         Enzyme-Linked Immunosorbent Assays,

·         Enzyme-Linked Immunospot

·         Immuno-PCR

·         Rapid Tests

·         Western Blotting

·         Others

Specimen Type Insight and Forecast 2022-2030

·         Blood

·         Urine

·         Saliva

·         Others

Application Insight and Forecast 2022-2030

·         Infectious Diseases

·         Oncology

·         Cardiology

·         Autoimmune Disorders

·         Neonatal Screening

·         Endocrinology

·         Bone & Mineral Disorders

·         Hematology & Blood Screening

·         Toxicology

·         Others

End User Insight and Forecast 2022-2030

·         Hospitals

·         Blood Banks

·         Clinical Laboratories

·         Pharmaceutical and Biotechnology Companies & CROs

·         Research & Academic Laboratories

·         Others

Geographical Viewpoint:

The research overview provides the major industry trend and the global market's predicted volume based on the regional analysis. The elements that have driven and hampered the market's expansion are also mentioned in this market research analysis. The study is also equipped with the most advanced and effective techniques for gathering, recording, estimating, and evaluating market data.

FAQ

1.      Who are the most dominant players in the global market, and what elements are assisting them in gaining a competitive advantage?

2.      What are the strategies adopted by the key industry players to gain traction in the industry?

3.      By the end of the forecast period, what will the market size and growth rate?

4.      What are the biggest Global Immunoassay Market trends that are influencing market growth?

5.      In the global market, which segment had the biggest revenue share?

Explore More Reports by VynZ Research:

Global Patient Monitoring Device Market – Analysis and Forecast 2022-2030

Global Hernia Repair Market – Analysis and Forecast 2022-2030

Global Diagnostic Imaging Market – Analysis and Forecast 2022-2030

Global Point of Care/Rapid Diagnostic Market – Analysis and Forecast 2022-2030

About VynZ Research

VynZ Research is a global market research firm offering research, analytics, and consulting services on business strategies. VynZ have a recognized trajectory record and our research database is used by many renowned companies and institutions in the world to strategize and revolutionize business opportunities. The company focuses on providing valuable insights on various technology verticals such as Chemicals, Automotive, Transportation, Energy, Consumer Durables, Healthcare, ICT and other emerging technologies.

[marketresearch-articles]

Immunoassay Reagents and Devices Market Size, Exclusive Research Report by The Insight Partners

Immunoassay Reagents and Devices Market is grow at a CAGR 4.9% in the forecast 2021 to 2028.

Immunoassay Reagents and Devices Market Scope and Size

·        On the basis of product, the immunoassay reagents and devices market is segmented into reagents & kits and analyzers. In 2021, reagents & kits segment is dominating due to its higher usage in drug development as well as in disease detection.

·        On the basis of platform, the immunoassay reagents and devices market is segmented into chemiluminescence immunoassays, fluorescence immunoassays, enzyme immunoassay, radioimmunoassays and others. In 2021, enzyme immunoassay segment is dominating the market because of its advantages such as ease in performing test, accurate result and many others.

·        On the basis of technique, the immunoassay reagents and devices market is segmented into enzyme-linked immunosorbent assays, rapid tests, enzyme-linked immunospot, western blotting, immuno-PCR and other techniques. In 2021, enzyme-linked immunosorbent assays segment is dominating because it is highly sensitive, simple to perform, offer accurate result for any disease detection or in any drug development.

·        On the basis of specimen type, the immunoassay reagents and devices market is segmented into saliva, urine, blood and others. In 2021, blood segment is dominating the market because antigen can be easily detected from the blood.

·        On the basis of application, the immunoassay reagents and devices market is segmented into infectious diseases, oncology and endocrinology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, toxicology, neonatal screening and other applications. In 2021, oncology and endocrinology segment is dominating because of high incidence rate worldwide which can be detected easily with the use of immunoassays.

Get the sample copy of Report https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-immunoassay-reagents-and-devices-market

Global Immunoassay Reagents and Devices Market Country Level Analysis

Global immunoassay reagents and devices market is analyzed and market size information is provided by the country, product, platform, technique, specimen type, application and end user as referenced above.

 The countries covered in the global immunoassay reagents and devices market report are the U.S., Canada, Mexico, Germany, Italy, France, U.K., Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, rest of Europe, China, Japan, India, Australia, Singapore, Indonesia, Thailand, South Korea, Malaysia, Philippines, rest of Asia-Pacific, Brazil, Argentina, rest of South America, Saudi Arabia, South Africa, Egypt, UAE, Israel and rest of Middle East and Africa.

Immunoassay Reagents and Devices Market research report indicates that the global Immunoassay Reagents and Devices Market is expected to surge at a steady rate in the coming years. The report provides a comprehensive review of the global market. Analysts have identified the key drivers and restraints in the overall market. The historical milestones achieved by the global market and emerging trends have also been studied in this report. Adopting such market research report is becoming very essential for the businesses as it supports with the better decision making, revenue generation, prioritizing market goals and profitable business.

 The report is objective in nature but includes valuable comments by subject-matter experts. The Immunoassay Reagents and Devices Market research report authenticates and affirms the findings listed by the research analysts. The investigative approach of the research report allows the readers to get a detailed understanding of the finest nuances affecting the market dynamics. This report opens a discussion about the changing economy, governing policies, and political shifts that are expected to shape the market. Moreover, the report assists you in figuring out brand awareness, market landscape, possible future issues, industry trends and customer behaviour which ultimately leads to refined business strategies.

MAJOR TOC OF THE REPORT

Chapter One: Immunoassay Reagents and Devices Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three : Immunoassay Reagents and Devices Market Competition, by Players

Chapter Four: Global Immunoassay Reagents and Devices Market Market Size by Regions

Chapter Five: North Immunoassay Reagents and Devices Market by Countries

Chapter Six: Europe Immunoassay Reagents and Devices Market Revenue by Countries

Chapter Seven: Asia-Pacific Immunoassay Reagents and Devices Market Revenue by Countries

Chapter Eight: South Automotive Immunoassay Reagents and Devices Market Revenue by Countries

Chapter Nine: Middle East and Immunoassay Reagents and Devices Market Revenue Equipment by Countries

Chapter Ten: Global Immunoassay Reagents and Devices Market Segment by Type

Chapter Eleven: Global Immunoassay Reagents and Devices Market by Application

Get TOC Details:   https://www.databridgemarketresearch.com/toc/?dbmr=global-immunoassay-reagents-and-devices-market

major companies dealing in the global immunoassay reagents and devices market report are F. Hoffmann-La Roche Ltd, Siemens, Randox Laboratories Ltd., Abbott, Bio-Rad Laboratories, Inc., Merck KGaA, Beckman Coulter, Inc. (a subsidiary of Danaher), Sysmex Corporation, bioMérieux SA, Thermo Fisher Scientific, Inc., BD, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., DiaSorin S.p.A, Ortho Clinical Diagnostics, QIAGEN, Quidel Corporation, BioCheck, Inc., Bio-Techne, PerkinElmer Inc., Agilent Technologies, Inc., Luminex Corporation, MESO SCALE DIAGNOSTICS, LLC among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Access Full Report   https://www.databridgemarketresearch.com/reports/global-immunoassay-reagents-and-devices-market

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

Browse Related Reports@

Medical Waste Management Market

Yeast Protein Expression Service Market

[soumyafwr]

https://twikkers.nl/blogs/175011/Immuno-Oncology-Assays-Market-Size-Share-and-Forecast-2031

Immuno Oncology Assays Market Size, Share and Forecast 2031

[healthcareindustrynews]

Immuno Oncology Assays Market: Increased Demand for Personalized Medicine

This study involved four major activities in estimating the current size of the immuno-oncology assays market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size. Expected Revenue Growth: [214 Pages Report] The global immuno-oncology assays market is projected to reach USD 7.9 billion by 2026 from USD 4.4 billion in 2021, at a CAGR of 12.5%. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52562166 Key Factors Driving Market Growth: Market growth is driven by the increased demand for personalized medicine, rising incidence of cancer and the growing adoption of targeted therapy, and the growing significance of companion diagnostics in drug development. “In 2020, consumables segment accounted for the largest share of the immuno-oncology assays market, by product & service” Based on product & service, the cancer cell-based assays market is segmented into consumables, instruments, and software & services. The consumables segment accounted for the largest share of the cancer cell-based assays market in 2020. The requirement of consumables in large numbers as compared to instruments is the main factor driving the growth of this segment. In 2020, PCR segment accounted for the largest share in the market, by technology The cancer cell-based assays market is segmented into PCR, immunoassay, NGS, flow cytometry, and ISH based on technology. In 2020, the PCR segment accounted for the largest share. The growing use of PCR in immuno-oncology biomarker identification and discovery research is driving the growth of this segment. In 2020, research applications segment accounted for the largest share in the market, by application The immuno-oncology assays market is segmented into research applications and clinical diagnostics based on application. In 2020, the research applications segment accounted for the largest share of the cancer cell-based assays market. The rising prominence of biomarker-based drug development is driving the growth of this segment. Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=52562166 Regional Growth Analysis: North America is the largest regional market for immuno-oncology assays The global immuno-oncology assays market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global market. The North American cancer cell-based assays market growth can be attributed to the increasing demand for personalized medicine, rising adoption of advanced omics technologies for biomarker discovery, and growing government support for the discovery and development of biomarkers. Key Players: The major players operating in this market are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Illumina, Inc. (US), NanoString Technologies, Inc. (US), Sartorius AG (Germany), HTG Molecular Diagnostics, Inc. (US), QIAGEN N.V. (Netherlands), Merck Millipore (US), PerkinElmer, Inc. (US), Abbott Laboratories, Inc. (US), Guardant Health, Inc. (US), bioMérieux SA (France), Myriad Genetics, Inc. (US), MESO SCALE DIAGNOSTICS, LLC. (US), Seegene Inc. (South Korea), Bio-Rad Laboratories, Inc. (US), Charles River Laboratories, Inc. (US), Olink (Sweden), ASURAGEN, INC. (US), Invivoscribe, Inc. (US), Creative Biolabs (US), ReachBio LLC (US), and NMI Technologietransfer GmbH (Germany). Thermo Fisher Scientific, Inc. held the leading position in the cancer cell-based assays market in 2020. The company has maintained a leading position in the

market through its strong distribution networks across North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The company adopts organic growth strategies to increase its dominance in this market. For instance, in 2018, Thermo Fisher launched three assays, namely, Oncomine TCR Beta-SR Assay, Ion Torrent Oncomine Pan-Cancer Cell-Free Assay, and Torrent Oncomine Tumor Mutation Load Assay to address the challenges in this market.

[bhandvalkar94]

The major players in the market are Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Illumina, Inc., PerkinElmer, Inc., Crown Bioscience Inc., InSphero Inc., Merck & Company, Inc., F.Hoffmann-La Roche Ltd., HTG Molecular Diagnostics, Inc., among others

[healtcare]

Global Haematology and Flow Cytometry Market

Global Haematology and Flow Cytometry Market is expected to reach $XX Mn by 2026 from $XX Mn in 2019, at a CAGR of 8.5% during forecast period.

Global Haematology and Flow Cytometry Market Overview:

Hematology is a medical specialty that deals with the study and treatment of blood. This is concerned with the diagnosis, study, treatment, and prevention of blood diseases. Flow cytometry is an analytical tool that is used in the measurement and analysis of several physical characteristics of cells or particles suspended in a fluid using a laser beam. The method helps to subclassify cell types to decide on the best treatment plan.

Global Haematology and Flow Cytometry Market Dynamics:

Rising global incidence and prevalence of chronic diseases like blood cancer is the major driving factor for the market growth. According to the National Cancer Institute in 2018, it was being estimated that 60,300 new leukemia cases are diagnosed and the deaths are around 24,470 cases in the United States. The increasing number of HIV cases globally is an important driver for the flow cytometry market. This is because the flow cytometry technique has its direct application in HIV diagnosis. According To UNAIDS in 2017, 31.1-43.9 million people globally are living with HIV by out of which 1.8 million are newly affected with HIV. Flow cytometry uses light scattering to determine the identity of cells. Increasing adoption of flow cytometry techniques in research and academia and growing initiatives in the field of immunology and Immuno-oncology researches are expected to propel the growth of the global flow cytometry market. Growth in stem cell research and the development of high-throughput flow cytometry technologies are likely to add new opportunities for this market in the coming years. Increasing regulatory approval and the introduction of technologically advanced flow cytometry solutions are expected to facilitate market growth over the forecast period. For instance, in June 2020, Sysmex Corporation launched the XF-1600 flow cytometer for laboratories, in North America. A significant restraint on the flow cytometry market is the availability of cheaper and better alternatives. ELISA (enzyme-linked immunosorbent assay) and radioimmunoassay are two of these alternatives. Although flow cytometry, ELISA, and radioimmunoassay are all methods for detecting "problem cells" in a community of cells, ELISA and radioimmunoassay are less expensive and easier to use. Along with this, the dearth of skilled technicians for managing such advanced technology is expected to restrain the market growth. The report has profiled twenty key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.

Global Haematology and Flow Cytometry Market Segment Analysis:

The Global Haematology and Flow Cytometry Market is segment on the basis of Product, Technology and End-Users. Based on Product, the flow cytometry instruments segment is expected to dominate the global market. The segment is further classified into cell analyzers and cell sorters. It held a market share of 25% in 2020. This high share is attributed to new advancements in technology and the introduction of novel cytometers by key players. The high price of these instruments is also contributing toward the high revenue generation in this segment. Along with this, reagents and consumables also held a prominent share in 2020. Owing to their increased adoption in diagnostics and research the segment is expected to register lucrative growth over the forecast period. The large share of this segment is mainly attributed to the growing research activities to develop and prove the efficacy of various assays and kits, and the commercialization of high-quality and application-specific consumables, reagents, and assays. Based on technology, the cell-based flow cytometry segment held the largest market share of 76% in 2020. The highest share is due to an increase in demand for early diagnosis and increased understanding of the related benefits of cell-based assays. In addition, advances in cell-based assay technology, such as innovations in tools, labels, affinity reagents, software, and algorithms, are expected to accelerate adoption in the coming years. To know about the Research Methodology :- Request Free Sample Report

Global Haematology and Flow Cytometry Market Regional Insights:

North America dominated the global market in 2020. The region dominated the global market in 2020 by holding a market share of 39.1%. This dominance is attributed due to the United States' high healthcare spending, well-developed healthcare system, and widespread adoption of technologically advanced flow cytometry solutions. In addition, the established pharmaceutical industry, as well as extensive research activities by research universities and pharmaceutical companies has generated huge demand for flow cytometry solutions for research universities and pharmaceutical companies have created a huge demand for flow cytometry solutions for research needs. APAC region is projected to exhibit highest CAGR during forecast period. This high growth can be attributed to the extensive growth in the pharmaceutical and biotechnology industries of emerging economies, such as China and India. The lucrative growth exhibited by this region is also an outcome of continuous government support for the establishment of the pharmaceutical industry in emerging countries. The report also helps in understanding Global Haematology and Flow Cytometrys Market dynamics, structure by analyzing the market segments and project the Global Haematology and Flow Cytometrys Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Haematology and Flow Cytometrys Market make the report investor’s guide.

Global Haematology and Flow Cytometry Market, key developments:

• In September 2018, the U.S. FDA awarded a grant of ~$18 million over a period of four years for 12 new clinical trials. These clinical trials are aimed at developing products for patients with rare diseases (including primary sclerosing cholangitis, stargardt disease, Cushing disease, acute myeloid leukemia, and graft versus host disease, among others). • In March 2017, Cytek Biosciences Inc., a manufacturer and supplier of flow cytometry products and services launched its DxP Athena flow cytometry system. The system is compact, powerful, easy-to-use cell analyzer that are typically only found in conventional instruments that come with a much higher price tag. The DxP Athena makes the benefits of flow cytometry which are more readily available to larger number of researchers by its compact size. • In 2016, the Global Clinical Trials Fund (U.K.) launched a dedicated fund with an upper limit of $662,185 to support clinical trials across the world related to the testing of new experimental drugs and existing drugs developed for dementia.

Global Haematology and Flow Cytometry Market Scope: Inquire before buying

Global Haematology and Flow Cytometry Market, by Region:

• North America • Europe • South America • MEA • APAC

Global Haematology and Flow Cytometry Market, Key players:

• Becton, Dickinson and Company • Beckman Coulter, Inc. • Bio-Rad Laboratories, Inc. • Thermo Fisher Scientific, Inc. • Merck KGaA • Sysmex Partec GmbH • Luminex Corporation • Miltenyi Biotec GmbH • Sony Biotechnology • Abbott • Agilent Technologies • CellaVision • Horiba • Nihon Kohden • Ortho-Clinical Diagnostics • Roche • Siemens Healthineers • Sysmex • Miltenyi Biotec • Apogee Flow Systems Ltd.

[jane2000doeaka]

Global Immuno Oncology Assays market was valued at around USD 4.4 billion in 2021 and is expected to grow with the CAGR of 16.5% during forecast period 2021-2027.

[gmiresearch]

Immuno Oncology Assays Market Research Report

Immuno Oncology Assays Market

Growth opportunities in the immuno oncology assays market look promising over the next six years. This is mainly due to the continuous expansion by emerging countries and the rising demand for personalized medicines.

Request for a FREE Sample Report on Immuno Oncology Assays Market

Immuno Oncology Assays Market Dynamics (including market size, share, trends, forecast, growth, forecast, and industry analysis)

Key Drivers

The surging demand for customized medicines, along with the rising occurrence of cancer and the augmenting acquisition of targeted therapy, are some of the prominent factors stimulating the growth of the global immuno oncology assays market. Also, cancer is a complicated disease developed through a multi-stage carcinogenesis process, including several molecular pathway events. In accordance with the GLOBOCAN, the aggregate cancer cases are rising and are anticipated to extend to 30 million by the end of 2040, which was 18 million in 2018. Asia, Africa, and the U.S. are witnessing approximately 605 cancer cases. Thus, the growing incidence of cancer is fuelling the market growth.  

Moreover, developing nations which include China, Brazil, India, and South Korea, are progressively emphasizing strengthening the spending on healthcare which is further promoting the market growth. According to the World Health Organisation, the health expenditure in 2018 totaled 5.3 % which was 5.1 % in 2017. However, the lower cost-benefit ratio and the requirement of huge capital investment are constraining the immuno oncology assays market size.

Product & Service Segment Drivers

Based on the product & service, the reagents and antibodies are predicted to expand at a higher CAGR during the forecast period. This is because of the rising prevalence of different types of cancer. The escalating number of cancer patients is primarily due to population growth and aging.  Cancer-related lungs and female breasts are the most common categories in the world.

Regional Drivers

Based on the regional coverage, North America is projected to lead the market during the forecast period. This is mainly due to the extreme pervasiveness of cancer. The National Institutes of Health (NIH), in 2018, reported that there were 1,735,350 new cases of cancer in the U.S., with 609,640 deaths. On the other hand, the Asia-Pacific is expected to increase at a faster CAGR during the forecast period. This is due to the increasing assistance from government bodies and the high prevalence of cancer.

Immuno Oncology Assays Market’s leading Manufacturers:

·         Perkinelmer, Inc.

·         Nanostring Technologies, Inc.

·         Abbott

·         Merck KGaA

·         F. Hoffmann-La Roche Ltd.

·         HTG Molecular Diagnostics, Inc.

·         Sartorius AG

·         Agilent Technologies, Inc.

·         Illumina, Inc.

·         Thermo Fisher Scientific Inc.

Immuno Oncology Assays Market Segmentation:

Segmentation by Products & Service

·         Reagents and Antibodies

·         Instruments

·         Software

·         Consumables and Accessories

Segmentation by Technology

·         Polymerase Chain Reaction

·         Immunoassay

·         Next-Generation Sequencing

·         In Situ Hybridization

·         Flow Cytometry

Segmentation by Indication

·         Lung Cancer

·         Breast Cancer

·         Colorectal Cancer

·         Bladder Cancer

·         Melanoma

·         Others

Segmentation by Application

·         Research Applications

·         Clinical Diagnostic

Segmentation by Region:

·         North America

o   United States of America

o   Canada

·         Asia Pacific

o   China

o   Japan

o   India

o   Rest of APAC

·         Europe

o   United Kingdom

o   Germany

o   France

o   Spain

o   Rest of Europe

·         RoW

o   Brazil

o   South Africa

o   Saudi Arabia

o   UAE

o   Rest of the world (remaining countries of the LAMEA region)

About GMI Research

GMI Research is a market research and consulting company that offers business insights and market research reports for large and small & medium enterprises. Our detailed reports help the clients to make strategic business policies and achieve sustainable growth in the particular market domain. The company's large team of seasoned analysts and industry experts with experience from different regions such as Asia-Pacific, Europe, North America, among others, provides a one-stop solution for the client. Our market research report has in-depth analysis, which includes refined forecasts, a bird's eye view of the competitive landscape, key factors influencing the market growth, and various other market insights to aid companies in making strategic decisions. Featured in the 'Top 20 Most Promising Market Research Consultants' list of Silicon India Magazine in 2018, we at GMI Research are always looking forward to helping our clients to stay ahead of the curve.

Media Contact Company Name: GMI RESEARCH Contact Person: Sarah Nash Email: enquiry@gmiresearch.com Phone: Europe – +353 1 442 8820; US – +1 860 881 2270 Address: Dublin, Ireland Website: www.gmiresearch.com